Company Summary

Founded on ground-breaking discoveries from researchers at Columbia University, Keren Therapeutics is harnessing the biology of a naturally occurring peptide hormone to restore muscle function in the context of several musculoskeletal and muscle wasting diseases. Using the same biological insights, Keren is also developing a therapeutic to counteract cognitive decline associated with age-related neurodegenerative conditions.

Year Founded:  2017

Key Executives:
• Peter Alff, Executive in Residence

Location:  New York, NY

Company Status:  Private

Year Invested:  2018

Investment Status:  Current

Board Members:
Nikos Iatropoulos
• Carol Kachmer
Peter Alff